ABVC - ABVC BioPharma GAAP EPS of -$0.06 beats by $0.07 revenue of $0.31M beats by $0.3M August, 17 2022 08:43 AM ABVC BioPharma Inc. ABVC BioPharma press release ( NASDAQ: ABVC ): Q2 GAAP EPS of -$0.06 beats by $0.07 . Revenue of $0.31M (+933.3% Y/Y) beats by $0.3M . For further details see: ABVC BioPharma GAAP EPS of -$0.06 beats by $0.07, revenue of $0.31M beats by $0.3M